O Espitia
Overview
Explore the profile of O Espitia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elias A, Debourdeau P, Espitia O, Sevestre M, Girard P, Mahe I, et al.
Rev Med Interne
. 2024 Jun;
45(6):354-365.
PMID: 38823999
Catheter-related thrombosis (CRT) is a relatively frequent and potentially fatal complication arising in patients with cancer who require a central catheter placement for intravenous treatment. In everyday practice, CRT remains...
2.
Bertoletti L, Girard P, Elias A, Espitia O, Schmidt J, Couturaud F, et al.
Rev Med Interne
. 2024 May;
45(5):289-299.
PMID: 38806295
Patients with cancer are at significantly increased risk of venous thromboembolism (VTE), due both to the impact of malignant disease itself and to the impact of certain anticancer drugs on...
3.
Guedon A, Froger C, Agard C, Benichou A, Le Jeune S, Mekinian A, et al.
QJM
. 2024 May;
117(11):769-776.
PMID: 38806178
Objective: Giant cell arteritis (GCA) is one of the most common large vessel (LVV) vasculitis and is associated with a high risk of relapse and cardiovascular complications. Improving risk stratification...
4.
Hankard A, Maalouf G, Laouni J, Espitia O, Agard C, De Boysson H, et al.
J Autoimmun
. 2024 May;
146:103242.
PMID: 38761452
Objective: To assess the prognosis and outcome of patients with isolated carotid vasculitis. Methods: We performed a retrospective multicenter study of 36 patients (median age at diagnosis was 37 [IQR...
5.
Renaud A, Jirka A, Durant C, Connault J, Espitia O, Takoudju C, et al.
Rev Med Interne
. 2023 Jun;
44(8):410-422.
PMID: 37270380
Gastrointestinal tract involvement in systemic sclerosis concerns more than 90% of patients but is of heterogeneous clinical expression. It can involve the entire intestinal tract and be responsible for multifactorial...
6.
Renaud A, Durant C, Achille A, Artifoni M, Espitia O, Agard C
Rev Med Interne
. 2020 Nov;
42(2):86-92.
PMID: 33129579
Introduction: Pharmaceutical prescription in systemic sclerosis is guided by national and international recommendations. This study's primary objective was to describe and analyze these prescriptions among patients of our cohort. We...
7.
Constant Dit Beaufils P, de Gaalon S, Espitia O, Ploton G, Mercier S, Liberge R, et al.
Rev Med Interne
. 2020 Jun;
41(9):628-631.
PMID: 32565074
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by the triad of nose bleeding, telangiectasia and familial heredity. Case Report: We report the case of a patient...
8.
Agard C, Bonnard G, Samson M, de Moreuil C, Lavigne C, Jego P, et al.
Scand J Rheumatol
. 2019 Nov;
48(6):474-481.
PMID: 31766965
: To compare the clinical presentation and outcome of giant cell arteritis (GCA)-related aortitis according to the results of temporal artery biopsy (TAB).: Patients with GCA-related aortitis diagnosed between 2000...
9.
Deshayes S, Liozon E, Chanson N, Sacre K, Moulinet T, Blanchard-Delaunay C, et al.
Clin Rheumatol
. 2019 Jan;
38(5):1243-1249.
PMID: 30617596
Introduction: Some studies suggest that there is an increased risk of malignancies in giant cell arteritis (GCA). We aimed to describe the clinical characteristics and outcomes of GCA patients with...
10.
Espitia O, Agard C, Pistorius M
Br J Dermatol
. 2018 Oct;
179(4):e168.
PMID: 30318798
No abstract available.